InMed Pharmaceuticals Inc.
INM | NASDAQ
$13.21
-$4.29 (-24.53%)
At close: Nov 5, 2026, 4:00 PM ET
$13.53
+$0.32 (+2.42%)
After-hours:
Nov 5, 2026, 4:28 PM ET
Fiscal Quarter Period Ending | Q1 2027 Sep 30, 2026 | Q4 2026 Jun 30, 2026 | Q3 2026 Mar 31, 2026 | Q2 2026 Dec 31, 2025 | Q1 2026 Sep 30, 2025 | Q4 2025 Jun 30, 2025 | Q3 2025 Mar 31, 2025 | Q2 2025 Dec 31, 2024 | Q1 2025 Sep 30, 2024 | Q4 2024 Jun 30, 2024 | Q3 2024 Mar 31, 2024 | Q2 2024 Dec 31, 2023 | Q1 2024 Sep 30, 2023 | Q4 2023 Jun 30, 2023 | Q3 2023 Mar 31, 2023 | Q2 2023 Dec 31, 2022 | Q1 2023 Sep 30, 2022 | Q4 2022 Jun 30, 2022 | Q3 2022 Mar 31, 2022 | Q2 2022 Dec 31, 2021 | Q1 2022 Sep 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -2.33B | -14.58B | -2.79M | -3.75B | -2.41M | -1.79M | -2.12M | -2.58M | -1.68M | -1.94M | -1.72M | -1.48M | -2.54M | -338.39K | -2M | -2.1M | -3.51M | -7.87M | -3.48M | -4.28M | -2.97M |
Depreciation & Amortization | 221.04M | 260.2K | 133.46K | 158.02K | 156.68K | 131.08K | 129.58K | 129.08K | 144.98K | 151.86K | 150.69K | 152.61K | 149.36K | 150.97K | 142.62K | 147.36K | 148.51K | 144.52K | 142.79K | 138.06K | 54.44K |
Stock-Based Compensation | 16.38M | 132.02M | 38.77K | 45.45M | 20.21K | 26.73K | 40.45K | 23.16K | 28.96K | 38.95K | 55.31K | 18.26K | 25.19K | 40.48K | 50.36K | 70.64K | 116.68K | 176.89K | 195.09K | 214.78K | 111.14K |
Other Working Capital | 231.51K | 769.03K | n/a | -786.98K | 31.42K | 66.04K | 81.28K | -232.91K | -420.03K | 903.55K | -134.9K | -955.85K | -16.17K | 198.16K | 52.11K | -1.03M | 201.6K | -176.52K | -1.66M | 480.04K | 171.21K |
Other Non-Cash Items | 950.14M | 14.45B | 1.04M | 3.71B | 71.72K | 32.88K | 25.98K | 14.71K | 4.75K | 52.08K | 1.38K | 195.1K | -538 | -435.93K | -44.77K | 125.06K | 579.45K | 4.99M | 162.06K | -83.22K | -17.43K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 94.95K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.26K |
Change in Working Capital | 882.09K | -962.2K | -183.78K | -821.01K | -82.23K | -180.88K | 265.42K | -94.07K | -327.64K | 665.61K | -418.82K | -705.04K | 93.65K | -153.82K | 245.43K | -955.06K | 410.02K | -1.25M | -2.1M | 480.68K | 168.29K |
Operating Cash Flow | -1.14B | -2.91M | -1.76M | -3.23M | -2.24M | -1.78M | -1.66M | -2.5M | -1.83M | -1.03M | -1.93M | -1.82M | -2.17M | -736.69K | -1.65M | -2.71M | -2.26M | -3.99M | -5.27M | -3.53M | -2.65M |
Capital Expenditures | n/a | n/a | 4 | 5.49 | n/a | n/a | n/a | n/a | n/a | 92 | n/a | -9.22K | n/a | -159.6K | 4.76 | n/a | n/a | 76.80 | -3.31K | -35.55K | n/a |
Cash Acquisitions | 2.42K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 490.38K | -490.38K | n/a | 90.78K | n/a | n/a | n/a |
Purchase of Investments | n/a | -45.49M | -16.95K | -25.14M | -20.96K | -2.23K | -16.04K | -2.68K | -21.32K | 431 | -21.2K | 163.66 | -21.32K | -42.16K | n/a | n/a | n/a | -421.36K | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | 45.49M | 16.95K | 25.14M | 20.96K | 2.23K | 16.04K | 2.68K | 21.32K | -431 | 21.2K | -163 | 21.32K | 42.16K | n/a | n/a | n/a | -90.97K | -581 | 91.55K | n/a |
Other Investing Acitivies | 2.41M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 118.45K | -618.94K | -9.62K | n/a | -297.88K | n/a | 250K | -250K |
Investing Cash Flow | 2.42M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 87.86 | n/a | -9.22K | n/a | -41.15K | -128.57K | -500K | n/a | -719.34K | -3.89K | 306K | -250K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 393.68K | -24.95K | -657.06K | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | -431.66M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 39.96M | 431.66M | n/a | n/a | n/a | 4.41M | -15.1K | -57.63K | -191.82K | 44K | n/a | n/a | n/a | n/a | n/a | 571.26K | -571.26K | n/a | n/a | n/a | -1.12M |
Financial Cash Flow | 40M | -827 | 231.48K | 1.16K | -191.33K | 8.17M | 2.92M | 338.52K | 838.24K | 176 | 34.79K | 4.62M | n/a | 129.7K | -14.24K | 5.32M | 5.43M | 4.99M | -92.93K | -838.25K | 10.88M |
Net Cash Flow | -1.1B | -2.96M | -1.8M | -3.26M | -2.43M | 6.4M | 1.26M | -2.16M | -988.57K | -1.03M | -1.93M | 2.8M | -2.17M | -691.54K | -1.85M | 2.1M | 3.17M | 278.55K | -5.38M | -4.06M | 7.98M |
Free Cash Flow | -1.14B | -2.91M | -1.76M | -3.23M | -2.24M | -1.78M | -1.66M | -2.5M | -1.83M | -1.03M | -1.93M | -1.83M | -2.17M | -896.29K | -1.65M | -2.71M | -2.26M | -3.99M | -5.28M | -3.57M | -2.65M |
Adj. Free Cash Flow | -1.16B | -134.93M | -1.8M | -48.68M | -2.26M | -1.81M | -1.7M | -2.53M | -1.86M | -1.07M | -1.99M | -1.84M | -2.2M | -936.77K | -1.71M | -2.78M | -2.37M | -4.17M | -5.47M | -3.78M | -2.77M |
Maintenance CapEx | n/a | n/a | 4 | 10.98 | n/a | n/a | n/a | n/a | n/a | 92 | n/a | n/a | n/a | n/a | 9.52 | n/a | n/a | 153.59 | n/a | n/a | n/a |
Growth CapEx | n/a | n/a | n/a | -5.49 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -9.22K | n/a | -159.6K | -4.76 | n/a | n/a | -76.80 | -3.31K | -35.55K | n/a |
Owner Earnings | -1.14B | -2.91M | -1.76M | -3.23M | -2.24M | -1.78M | -1.66M | -2.5M | -1.83M | -1.03M | -1.93M | -1.82M | -2.17M | -736.69K | -1.65M | -2.71M | -2.26M | -3.99M | -5.27M | -3.53M | -2.65M |
Add to Watchlist
Select watchlists to add or remove INM